基于古今医案云平台分析中医药治疗急性心肌梗死用药规律
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R256.22

基金项目:

浙江省中医药科技计划项目(2024ZL117);浙江省中医药科技计划项目(2022ZQ062);祝光礼全国名老中医药专家传承工作室建设 项目(GZS202201)


Analysis on the Medication Law of Traditional Chinese Medicine in Treating Acute Myocardial Infarction Based on Ancient and Modern Medical Record Cloud Platform
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:运用古今医案云平台软件分析中医药治疗急性心肌梗死的用药规律。方法:检索中国知网、 万方学术期刊全文数据库、维普中文科技期刊数据库、PubMed、Embase、Web of Science数据库中公开发表的 中医药治疗急性心肌梗死的文献,提取中药处方数据,应用古今医案云平台软件的数据挖掘模块进行药物频次 的统计、属性(四气、五味、归经、功效) 分析、关联规则分析、聚类分析和复杂网络分析。结果:①共检索 到194首中药处方,涉及中药191味,累计频次1 745次。使用频次>20次的中药有20味,排名前5的中药依 次为丹参、黄芪、川芎、赤芍、当归。②中药属性分析结果。四气:以温为主,其次为微寒、平、寒、微温。 五味:以甘为主,其次为辛、苦、微苦、酸。归经:以肝为主,其次为心、肺、脾、胃。药物功效:以活血祛 瘀为主,其次为生津养血、通经止痛、凉血消痈、清心除烦。③关联规则分析结果。按照支持度从高到低排 列,排名前5的药对依次是黄芪-丹参、川芎-丹参、赤芍-丹参、当归-川芎、赤芍-川芎。④聚类分析结果。 共得到3个聚类。第1类:丹参、黄芪、川芎;第2类:麦冬、三七、人参、瓜蒌、炙甘草、桂枝;第3类:当 归、红花、桃仁、赤芍、党参、甘草。⑤复杂网络分析结果。得出核心处方药物组成为黄芪、丹参、川芎、赤 芍、当归、党参、红花、麦冬、三七、甘草。核心处方为补阳还五汤加减。结论:中医药治疗急性心肌梗死以 活血化瘀、补气健脾为主,辅以行气、凉血、养阴、生津,用药以味甘、性温、归肝经为主,临证应气血同 调,标本兼顾,五脏一体,识机辨证,在急性心肌梗死的治疗全程运用中医药干预,可改善急性心肌梗死预后 和减少并发症,提升中医药干预危重症的水平和力度。

    Abstract:

    Abstract Objective: To analyze the medication law of traditional Chinese medicine (TCM) in treating acute myocardial infarction by using the Ancient and Modern Medical Record Cloud Platform. Methods:The literature on the treatment of acute myocardial infarction with TCM published in China National Knowledge Infrustructure, WanFang Data Knowledge Service Platform,China Science and Technology Journal Database,PubMed,Embase,and Web of Science databases was searched. Extract TCM prescription data. The data mining module of the Ancient and Modern Medical Record Cloud Platform was used to conduct drug frequency statistics,attribute( four qi,five flavors,meridian tropism,efficacy) analysis,association rule analysis,cluster analysis and complex network analysis. Results:①A total of 194 Chinese medicine prescriptions were retrieved, involving 191 Chinese medicines, with a cumulative frequency of 1 745 times. There are 20 Chinese medicines that are used more than 20 times, and the top 5 Chinese medicines are Salviae Miltiorrhizae Radix et Rhizoma,Astragali Radix,chuanxiong Rhizoma,Paeoniae Radix Rubra and Angelicae sinensis Radix. ② Analysis results of attributes of Chinese medicine. Four Qi:mainly warm,followed by slightly cold,neutral,cold and slightly warm. Five flavors:mainly sweet,followed by pungent,bitter,slightly bitter and sour. Meridian tropism: mainly liver, followed by heart, lung, spleen and stomach. Drug efficacy: it mainly promotes blood circulation and removes blood stasis, followed by promoting fluid circulation and nourishing blood, dredging menstruation and relieving pain, cooling blood and eliminating carbuncle, clearing the heart and relieving troubles. ③ Analysis results of association rules. According to the degree of support from high to low,the top 5 medicine pairs are Astragali Radix-Salviae Miltiorrhizae Radix et Rhizoma,Chuanxiong Rhizoma-Salviae Miltiorrhizae Radix et Rhizoma, Paeoniae Radix Rubra-Salviae Miltiorrhizae Radix et Rhizoma, Angelicae Sinensis Radix-Chuanxiong Rhizoma, and Paeoniae Radix Rubra-Chuanxiong Rhizoma. ④Results of cluster analysis. A total of 3 clusters were obtained. Category 1: Salviae Miltiorrhizae Radix et Rhizoma, Astragali Radix, Chuanxiong Rhizoma; Category 2: Ophiopogonis Radix, Notogyri Radix, Ginseng Radix et Rhizoma, Trichosanthis Fructus, Glycyrrhizae Radix et Rhizoma Praeparata cum Melle, Cinnamomi Ramulus; Category 3: Angelicae Sinensis Radix, Carthami Flos, Persicae Semen, Paeoniae Radix Rubra, Codonopsis Radix, Glycyrrhizae Radix et Rhizoma. ⑤Results of complex network analysis. It is concluded that the core prescription medicine composition is Astragali Radix, Salviae Miltiorrhizae Radix et Rhizoma, Chuanxiong Rhizoma, Paeoniae Radix Rubra, Angelicae Sinensis Radix, Codonopsis Radix, Carthami Flos, Ophiopogonis Radix, Notogyri Radix, Glycyrrhizae Radix et Rhizoma. The core prescription is modified Buyang Huanwu Decoction. Conclusion: Chinese medicine treatment of acute myocardial infarction is mainly based on promoting blood circulation and removing blood stasis, tonifying qi and invigorating spleen,supplemented by promoting qi,cooling blood,nourishing yin and promoting fluid production. The medication should be sweet in flavor and warm in nature,mainly returning to the liver meridian,and the clinical symptoms should be coordinated with qi and blood, taking into account both of the symptoms and root cause, integrating five internal organs, analysising the pathogensis and differentiating syndromes. TCM intervention should be used in the whole process of acute myocardial infarction treatment to improve the prognosis of acute myocardial infarction, reduce complications and enhance the level and intensity of intervention by TCM.

    参考文献
    相似文献
    引证文献
引用本文

黄飞,范文权,陈超,祝丹,陈启兰,张杰.基于古今医案云平台分析中医药治疗急性心肌梗死用药规律[J].新中医,2025,57(5):7-13

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-03-17
  • 出版日期:
文章二维码